Podcasts about factors associated

Dr. Rosy Boa interviews exercise scientist and belly dance (Raqs Sharqi) teacher Siobhan Camille (MSc in Rehabilitation Science) about applying exercise science to dance and pole. Siobhan shares her path from New Zealand athlete to researcher and strength and conditioning coach, including belly dance injury research, hospital-based rehab work, and her current role with Dutch elite and Olympic sport. They discuss how early research in “fringe” activities often focuses on injury rates before performance optimization, and emphasize that rehab and return-to-sport/pole rely on principles tailored to the individual and their demands. Siobhan critiques common “prehab” trends that underload the body, argues that appropriate joint stress builds resilience, and highlights injury's multifactorial nature. They also cover consistency over optimization, motor learning cues, accessibility in classes, and misconceptions about “perfect posture” and pelvic tilt.Are you a pole nerd interested in trying out online pole classes with Slink Through Strength? We'd love to have you! Use the code “podcast” for 10% off the Intro Pack and try out all of our unique online pole classes: https://app.acuityscheduling.com/catalog/25a67bd1/?productId=1828315&clearCart=true  Links & citations: https://www.instagram.com/greenstonedancearts/ Athletic Performance and Rehabilitation work: https://siobhan-milner.com/ Greenstone Dance Arts:  https://greenstone.dance/ 6-Week Challenge: https://greenstone.dance/product/dance-strong-6-week-fitness-challenge-for-belly-dancers-plus-personalised-program/ Milner SC, Gray A, Bussey M. A Retrospective Study Investigating Injury Incidence and Factors Associated with Injury Among Belly Dancers. J Dance Med Sci. 2019 Mar 15;23(1):26-33. doi: 10.12678/1089-313X.23.1.26. PMID: 30835653. https://pubmed.ncbi.nlm.nih.gov/30835653/ Chapters: 00:00 Welcome and Guest Intro01:00 Siobhan's Dance and Sport Origins03:07 Research Path and Elite S&C Career05:13 From Injury Studies to Performance07:17 Rehab Principles and Return to Sport10:11 Prehab Means Getting Strong14:39 Load Management and Injury Complexity18:17 Aging, Consistency, and Staying Active22:11 Accessible Strength Training for Dancers26:54 Motor Learning and Better Cueing34:14 Posture Myths in Dance36:16 Where to Find Siobhan and Wrap Up

The correct treatment for rotator cuff tears remains a matter of debate. The varying characteristics of cuff tears – symptomatic versus asymptomatic, tear size, tendon quality, the presence of fatty atrophy, etc. – makes generalizations about the best treatment approach difficult. One thing shoulder specialists agree on is that tear enlargement is problematic. A cuff tear that enlarges may turn a once fixable tear into an unfixable one.  Predicting which tears will enlarge and the rate at which they will is not an exact science. We welcome Dr. James Irrgang, PT, PhD, FAPTA & Dr. Luke Mattar, PhD from the University of Pittsburgh to discuss their study looking at tear propagation trends in patients with a symptomatic, isolated supraspinatus tears after 3 month of an initial trial of physical therapy.

Date: February 13, 2026 Reference: Lang et al. Factors associated with emergency department length of stay in Alberta: a study of patient-, visit-, and facility-level factors using administrative health data. CJEM. 2026 Jan 29. Guest Skeptic: Dr. Paul Parks is an emergency physician from Medicine Hat, Alberta. He has been the President of the Alberta […] The post SGEM#503: Waiting is the Hardest Part – Factors Associated with ED LOS first appeared on The Skeptics Guide to Emergency Medicine.

In the first Clinical Update episode of 2026, MIMS Learning editors Dawn Liz Powell and Rhiannon Ashman look at the goals of MIMS Learning's new editorial campaign — Confidence in Obesity Care. One of the goals of the campaign is to help GPs and other healthcare professionals better understand the role of GLP-1 medications (also known as weight loss medications) in the management of obesity, looking at which medications can be prescribed in primary care and which patients are eligible for them.Another goal is to promote obesity management that encompasses the whole patient and not just their BMI.Dawn and Rhiannon also look at some of the complications of obesity, including cardio-renal-metabolic (CVRM) disease and young-onset type 2 diabetes.Educational objectivesAfter listening to this podcast, healthcare professionals should be better able to:Recall the prevalence of obesity and why its management is importantDiscuss what NHS programmes are available for supporting weight loss Recall the available management options for obesityState which patients are eligible for weight loss medicationsReview the connection between obesity and young-onset type 2 diabetesYou can access the website version of this podcast, along with a list of key learning points, on MIMS Learning - and make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.MIMS LearningRegister for a FREE accountCardio-renal-metabolic disease: clinical reviewConfidence in Obesity CareIdentifying and managing young-onset type 2 diabetesObesity in adultsAdult obstructive sleep apnoea syndrome: clinical reviewMIMSObesity treatments Hosted on Acast. See acast.com/privacy for more information.

Julie A. Parsons, MDHaberfield Endowed Chair in Pediatric Neuromuscular DisordersProfessor of Clinical Pediatrics and NeurologyUniversity of Colorado School of Medicine, Children's Hospital ColoradoAurora, CO, USANow, with our collective experience, we can at least put together the information that we have in terms of what can we expect and what's the timeline that we expect in terms of our patients having reactions. I will tell you, and I've said this multiple times, when I deliver a gene transfer therapy, I hold my breath for 2 months. Now, maybe it's going to have to be extended to a year, but it's typically at least for 2-3 months. It's like, okay, what's going to happen? You sit on the edge of your seat on pins and needles, going, "Is this kid going to be okay or not?" I think that's the appropriate response to have in terms of the light of things that have happened over time. We have to be really careful.We have a little bit of a framework now to say, when do we need to be really excited? We know that our patients, most all of them, are going to develop a transaminitis, and that ends up happening early on, but we get a couple of peaks. We get really excited that the 4-8 week time point with transaminitis looking for liver failure.The cholestatic liver disease that happened in the patients with X-linked MTM happened a little bit later, so Week 2, all the way out to six months afterwards. The acute cardiomyopathy a little bit earlier, so we're looking a little bit earlier for that effect. TMA, usually the end of the first week to about 2 weeks is when we would expect that to come in. Then the transgene-related myositis and immune-mediated myocarditis, weeks, maybe 2 to a couple of months.How do we adapt our gene transfer programs to the clinical trial experience? I think that there are a couple of points that are important. One is that the outline that I showed you, there are some disease-agnostic issues that come up with transaminitis, with TMA. I think there are some final common pathways related to the immune responses that we see with these patients. Then there are going to be some disease-specific disorders that are going to come up with each of these therapies and agents.We need to have good communication, honestly, in real-time. I still don't know that we have a good mechanism for that as a community, but to share these adverse events that come up so that we can all learn as a collective about what to expect, what to anticipate, and how to best take care of our patients. We know now how we need to monitor patients closely from a laboratory standpoint, from a clinical exam standpoint, and we really need to work on how are we going to mitigate some of these risk issues that we have with these patients.I think the collaborative aspect, particularly at meetings like this, is important. Last year, for the people that were at MDA, you remember that we really spent a lot of time looking at gene transfer delivery. Many of us got together as providers and actually met together to say, "Is there something that we can think about in terms of best practice or consensus in terms of how we would want to manage patients or how we'd want to share information?"Now, actually, on the MDA website, we really do have some guidelines, and there will be a publication coming out shortly that we'll have this available to everybody again. It's not necessarily the right answer, but it's at least from a collective experience, what's the best way that we can go forward? Some of the suggestions were that the adverse events right now, we can put them into some a predictable timeline, but we don't really know all the risks at the time of dosing.We know that gene transfer therapy can be safe for the right patient at the right time for the right disorder. That's really what we want to do. There's a Neurotherapeutic window between efficacy and toxicity. How are we adjusting that? What are we working on to make sure that we're getting that right? The preclinical data is helpful, but it's never the full story. Any time we go from a homogeneous population that we see in a clinical trial to a heterogeneous population, as we throw this out to the world, we're going to have new issues that arise, and we need to be aware and ready for those.We want to be able to predict what happens, but we can't always do that. Then follow-up is so important. The post-marketing study, sharing adverse events, sharing experiences, I think, is really important as well. Clinicians really should be familiar with this entire field before ever delivering gene transfer therapy. I don't think that every site should be delivering gene transfer. I think that from an institutional standpoint, you need to be ready. You need to have a team who knows what they're doing and knows how to handle the issues and the problems, or you need to have lifelines set up in advance if you're going to deliver these treatments.

How ready are EMS clinicians to care for patients who don't speak English—and what shapes that readiness? This new study explores the intersection of language access, EMS training, and clinician confidence when serving diverse communities. Join us this month for the Prehospital Care Research Forum Journal Club as the lead author shares what they uncovered and why it matters for future EMS education and policy. If you've ever faced a language barrier on scene, this conversation is for you.The article can be found at: Factors Associated with EMS Clinician Preparedness to Provide Care for Patients with Limited English Proficiency

PodChatLive 183: Why do bus drivers get foot issues, and the psychological factors associated with chronic ankle instabilityContact us: getinvolved@podchatlive.comLinks from todays episode:Chamonix Podiatry Ski Conference Musculoskeletal disorders among bus driversComparison of psychological factors between healthy athletes and those suffering from chronic ankle instabilityEffects of foot orthoses on lower extremity joint kinematics and kinetics in runners with asymptomatic flatfeet

Today's episode is kind of an Overtime / Ask The Sports Docs crossover. One of the PTs that Ashley works closely with asked her why some patients do well after ACL surgery and some don't fare as well, despite the surgery being identical in terms of technique, graft choice, post-op protocol etc. An article was just published in AJSM this month looking at this, specifically investigating factors that impact outcomes after ACL reconstruction. The article that we are reviewing today is titled “Primary Anterior Cruciate Ligament Reconstruction in Level 1 Athletes: Factors Associated With Return to Play, Reinjury, and Knee Function at 5 Years of Follow-up.” This level 2 cohort study aimed to analyze the outcomes of primary ACLR in level 1 athletes and identify preop and intraop factors associated with RTP, ipsilateral ACL reinjury, contralateral ACL injury, and IKDC score at 5 years post-op.** We have also been chatting about this episode offline and discussed an article that was recently published looking at preoperative grit scores and postoperative range of motion after ACL reconstruction. Grit score is another objective measurement that we can obtain preoperatively and perhaps use to guide intervention during post-op recovery. We actually did an Overtime episode looking at the impact of grit scores on post-op outcomes after ACL reconstruction. That is episode #53 if you want to check it out! But today's second article is titled “Higher Grit Scores Are Associated With Earlier Increases in Knee Flexion Following Anterior Cruciate Ligament Reconstruction With Meniscus Repair in Pediatric Patients.” It was published in the April 2023 issue of the Journal of Pediatrics. Pete Fabricant and his team at HSS found that patients with grit scores below the 50th percentile undergoing ACLR + meniscus repair have 5 degrees less total ROM at 3 months compared with those with high grit scores. Though 5 degrees might not seem like a lot, quicker motion recovery in patients with high grit may be a leading indicator of these patients likelihood to achieve other post-op milestones and meet criteria for RTS more quickly. This obvious needs future study to see how grit impacts other factors like strength gains, passing RTP assessments etc.

Biosimilars, a group of drugs that are similar to biologic drugs, which are medications produced using living organisms and are often used to treat complex medical conditions. Biosimilars were first introduced to the prescription drug market about a decade ago and as of March, the FDA had approved scores of products that may be used interchangeably for some of the most expensive brand-name biologic pharmaceuticals, treating conditions such as diabetes and cancer. While biologics make up only about 2% of prescriptions, they account for as much as 46% of total drug spending in the U.S.The three guests on this podcast all have expertise on different aspects of this topic and discuss the use of biosimilar medicines in health care and the possible cost savings when they are used in place of originator biologic medications. Luca Maini is an economist who studies the pharmaceutical industry and is an assistant professor at Harvard Medical School. Chad Pettit is executive director of global government affairs for Amgen, a biotechnology company. Erin Glossop is a policy specialist at NCSL who follows state policies around pharmaceuticals.Maini discussed his research into how the introduction of biosimilars into a market affects the price of brand-name biologics. Pettit explained the perspective from the biotechnology industry and how he thinks the industry will develop in the next several years. Glossop explained how some states are developing bipartisan policy around biosimilar access and efforts to find cost-savings these products might offer. ResourcesAmgen BiosimilarsAssessing the Biosimilar Void in the U.S., IQVIABiosimilars in the United States 2023-2027, IQVIABiosimilar Uptake In The US: Patient And Prescriber Factors, Dongzhe Hong, et al.Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans, James D. Chambers, et al.Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates, Mariana Socal, et al.Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans, Tianzhou Yu, et al.Luca Maini website

Author Minjin Fromm discusses her recent NASSJ article, "Factors associated with improved outcomes after lumbar transforaminal epidural steroid injections for radicular pain: A systematic review," with moderator and deputy editor Tobias Mattei.Read the full article here

Nonunion following naviculocuneiform (NC) joint arthrodesis is a well-recognized complication. Most studies reporting nonunion rates involve a limited number of cases or focus on a single disease entity. Moreover, there is variation between studies with regard to the number of articular facets included in the arthrodesis as well as the fixation construct used, with no clear evidence indicating how these factors influence union. This study, using the largest cohort to date, aims to investigate the nonunion rate following NC joint arthrodesis and to identify demographic and surgical factors associated with nonunion.   In conclusion, this study demonstrates a significant rate of nonunion following NC joint arthrodesis, exceeding that previously reported. We found that the rate of nonunion significantly increased in arthrodeses involving only the medial NC facet as compared to those including multiple NC facets.     Click here to read the article.

Today, we review the 2024 article that details the study of the risk factors associated with IAN injury after third molar removal. We welcome Dr. Jake Stucki back to the show – resident doctor at Case Western Reserve University School of Dental Medicine – as he outlines the study design of today's article in review. We unpack the variables focused on in the study, the risk factors that are revealed, how to mitigate these risks, and why the dental instruments for surgery need to be carefully chosen. To end, Dr. Jake walks us through other notable outcomes from the study, and we discover more ways to prevent nerve injuries during third molar removals.    Key Points From This Episode:The study design of the article in review: IAN injury risk factors after third molar removal.Patient demographics and other variables of focus in the study.  Where risk begins, how it grows, and how to minimize it.  Why the instruments you choose to use matter.   Other significant outcomes from the study and helpful supplementary resources.   Important advice for preventing nerve injuries. Dr. Jake Stucki on LinkedIn — https://www.linkedin.com/in/jake-stucki-ab19a593/  Case Western Reserve University School of Dental Medicine — https://case.edu/medicine/ ‘Risk Factors Associated with Inferior Alveolar Nerve Injury after Extraction of Impacted Lower Mandibular Third Molars: A Prospective Cohort Study' — https://www.joms.org/article/S0278-2391(24)00295-7/abstract  ‘The Radiological Prediction of Inferior Alveolar Nerve Injury during Third Molar Surgery' — https://pubmed.ncbi.nlm.nih.gov/2322523/  ‘Radiographic Predictors of Postoperative Inferior Alveolar Nerve Injury in Mandibular Third Molar Surgery' — https://www.joms.org/article/S0278-2391(24)00866-8/abstract ‘Dr. Tony Pogrel: Nuances of Coronectomy and Intentional Root Retention during Extraction' — https://www.buzzsprout.com/1404670/episodes/10507025-dr-tony-pogrel-nuances-of-coronectomy-and-intentional-root-retention-during-extraction.mp3  Journal of Oral Maxillofacial Surgery — https://www.joms.org/ Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

In this special sponsored episode, we explore the critical issue of non-ventilator hospital-acquired pneumonia (NV-HAP), the most common hospital-acquired infection. Dr. Barbara Quinn, a board-certified adult clinical nursing specialist with 30 years of experience, and Elias Coury, market director of quality and risk at Havasu Regional Medical Center and Valley View Medical Center, shed light on the underrecognized impact of NV-HAP. They discuss why prevention efforts often focus on ventilator-associated pneumonia, the role of oral care protocols, and practical strategies to improve patient safety and hospital outcomes. VISIT SPONSOR → https://KevinMD.com/Stryker SUBSCRIBE TO THE PODCAST → http://kevinmd.com/podcast

Martha Dewey Bergren, editor of The Journal of School Nursing, interviews author Nakia Best to discuss the article, "Exploration of Factors Associated with Reported Medication Administration Errors in North Carolina Public School Districts". The article can be found in Volume 40, Issue 5. To view the article, click here.

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Brad White from the Kansas State University Beef Cattle Institute to discuss a paper published in the Bovine Practitioner titled “Risk factors Associated with Case Fatality and Treatment Success following Initial Bovine Respiratory Disease Treatment in Feedyard Cattle”. This paper was a retrospective analysis of existing feedyard data to identify potential relationships between risk factors known at the time of initial treatment for bovine respiratory disease (BRD) and treatment outcomes. The three post-treatment outcomes evaluated were first treatment success, post-treatment deaths from any cause, and post-treatment deaths due to BRD.  The investigators found the overall first treatment success for BRD to be 67.8% with all-cause mortality of 10% and BRD related mortality of 6.3%. White discusses associations found with each post-treatment outcome evaluated which can be useful information as veterinarians evaluate the success of their BRD treatment, prevention and control protocols for their customers, and define expectations with clients.  Neal, K. B., White, B. J., Amrine, D. E., Lubbers, B. V., Tessman, R. K., & Larson, R. L. (2024). Risk factors Associated with Case Fatality and Treatment Success following Initial Bovine Respiratory Disease Treatment in Feedyard Cattle. The Bovine Practitioner, 58(2), 1–8. https://doi.org/10.21423/bovine-vol58no2p1-8 

Show notes at pharmacyjoe.com/episode943. In this episode, I'll discuss the risk factors associated with the development of venous thromboembolism in ICU patients. The post 943: Risk Factors Associated With the Development of Venous Thromboembolism in ICU Patients appeared first on Pharmacy Joe.

In Part 1 of a three-part Tendon special series of the Sports Therapy Association Podcast, host Matt Phillips of runchatlive.com speaks with renowned tendon researcher and educator, Professor Peter Malliaras, co-author of over 100 peer review publications and Associate Professor at Monash University Physiotherapy Department in Melbourne, Australia. Professor Malliaras is also creator of the internationally acclaimed 'Mastering Lower Limb Tendinopathy' course' (now in it's 7th edition), available online (16hours CPD) and face-to-face. Episode Timeline: 00:00 The Sports Therapy Association Podcast 00:59 Tendon Treatment, What the Research Says 03:10 Reflections on the Past 08:44 The Beginnings of Tendon Research 18:30 Factors Associated with Patella Tendinopathy 21:48 The Continuum Model and Clinical Practice 24:41 Changes in Nomenclature: Tendinitis vs. Tendinopathy 29:54 Evolution of Imaging in Tendinopathies 33:39 The Power of Imaging in Patient Engagement 35:31 Diagnosing Tendon Problems: What to Look For 39:52 Patient Presentation: Tendon vs. Muscular vs. Bone Issues 46:32 Moving Away from Treatment Protocols: Focus on Principles 48:21 Diverse Presentations and Varied Recovery Timelines 52:00 Gradual Loading Approaches for Individualized Rehab 54:47 Understanding Tendon Response to Loading: Not Black and White 55:58 Online Education: Tendinopathy Rehab Course Details 57:40 Importance of Applying Principles in Tendinopathy Management Other episodes in this Tendon series: Ep.199 - “Understanding Tendinopathies of The Hip And Pelvis” with special guest Dr Alison Grimaldi Ep200 - “Managing Tendon Pain” with special guest Dr Ebonie Rio Links • Peter Malliaras Website: https://www.tendinopathyrehab.site/ • Peter Malliaras Instagram:@tendinopathyrehab • Peter Malliaras Facebook:@tendinopathyrehab • Peter Malliaras Twitter: @DrPeteMalliaras Want to join the live recordings? Episodes of the Sports Therapy Association podcast are recorded live every TUESDAY at 8pm on the Sports Therapy Association YOUTUBE CHANNEL and FACEBOOK page. Everyone is welcome - you do not have to be an STA member! If you cannot join us live, be sure to subscribe to the 'Sports Therapy Association Podcast' on all popular podcast apps to be notified when new episodes are available. Please Support Our Podcast! If you appreciate what we do, please take a couple of minutes to leave us a rating & review on Apple Podcasts. It really does make all the difference in helping us reach out to a larger audience. iPhone users you can do this from your phone, Android users you will need to do it from iTunes. Questions? Email: matt@thesta.co.uk

This BJSM podcast discusses ACL reconstructions and when they may not meet the minimal important change (MIC) for the knee injury & osteoarthritis outcome score (KOOS) and quality of life (QoL). Dr Janina Kaarre and Dr Eric Hamrin Senorski discuss their latest research of ACL reconstruction outcomes from the Swedish National Knee Ligament Registry database and explain who may not benefit from surgical ACL reconstruction intervention. Hosted by Dr Shona Kohlhardt. Link to Paper: https://bjsm.bmj.com/content/57/9/528.abstract

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

⚡️⚡️⚡️در قسمت❌ دهم ❌In-Sight در مورد ریسک فاکتورهای شل شدن پیچ در اباتمنتهای کاستوم که با CADCAM ساخته میشن صحبت میکنیم.این ابسترکت مقاله مربوط به JPD هست.‼️‼️پادکست In-Sight مجموعه ای از پادکستهای کوتاهه که در اون ها ما بدون پرداختن به جزئیات ،خلاصه ی مقالات را مرور میکنیمپادکست In-Sight اپیزود میانی دنتکستهاستدکتر فواد شهابیان متخصص پروتز ،ایمپلنت زیباییاهواز کیانپارس061 3338 0090⚡️⚡️لینک ابسترکت مقاله❌❌

We answer a listener's question: Does age matter in a relationship? If you've ever wondered, How much of an age gap is OK?, tune in to hear:Age Gap Realities: We review the research, unpacking trends in happiness and commitment in age-discrepant relationships. Listen to hear science's mixed answer to the question, Can couples with large age gaps last? Beyond Years: We explore how age-gap couples relationships can thrive by focusing on shared values, speaking honestly about their goals, and planning for inevitable life stage differences.Resources and linksFor full show notes with links, visit relationshipcenter.com/podcastEp. 2 - What to Look for in a Long-Term PartnerWhat to Look for in Partner free guideMay-December paradoxes: An exploration of age-gap relationships in Western society.Globally, women are younger than their male partners, more likely to age aloneThe marital satisfaction of differently aged couplesA Review of the Factors Associated with Marital Satisfaction‘A Diamond is Forever' and Other Fairy Tales: The Relationship between Wedding Expenses and Marriage DurationGot a burning dating or relationship question for us? Call 415-573-0164 to leave us a voicemail! Alternatively, you can record an audio note on your phone and text it to that number, or email us at podcast@relationshipcenter.com. We may answer your question on an upcoming episode of the pod!

In this episode of the Journal of Black Psychology podcast series, Editor's Assistant Alexis Malone talks with Dr. Philip Baiden about the recently published study, "Risk and Protective Factors Associated with Suicidal Ideation and Suicide Attempts Among Black Adolescents Based on the 2017 Youth Risk Behavior Survey."

An Analysis of Musculoskeletal Disorder Risk Factors Associated with common Pedagogical Principles of the Lhevinne and Taubman Piano Schools – A Literature Review.

Dr Ishaan Swarup from UCSF joins the show this month to discuss distal tibial physeal fractures. Highlights from the lightning round include the interplay of race, socioeconomic status and self-image in scoliosis, measuring rotation with advanced imaging and clinical examination, and selective dorsal rhizotomy. Your hosts are Julia Sanders from Children's Hospital Colorado, Carter Clement from Children's Hospital of New Orleans, Craig Louer from Vanderbilt, and Josh Holt from University of Iowa. Music by A. A. Alto.   Citations for papers discussed can be found below:   Swarup I, Pearce R, Sanborn R, Shore BJ; Children's Orthopaedic Trauma and Infection Consortium for Evidence Based Studies (CORTICES). Variations in the Management of Closed Salter-Harris II Distal Tibia Fractures. J Pediatr Orthop. 2023;43(9):e742-e746.   Onay T, Çelen ZE, Bayhan M, Kandemir İ, Kiliç NC, Kayaalp ME. A More Conservative Approach in the Surgical Management of Pediatric Physeal Ankle Fractures Should be Preferred: Mid to Long-term Functional Outcomes of Three Different Surgical Techniques for Salter-Harris Type II and Triplane Distal Tibial Fractures. J Pediatr Orthop. 2023;43(9):e734-e741.   Sheth M, Kitziger R, Bindner C, Rosenfeld SB. Computed Tomography Analysis of Distal Tibia Physeal Fracture Patterns: A Classification and Technique for Optimizing Screw Trajectory [published online ahead of print, 2023 Aug 29]. J Pediatr Orthop. 2023;10.1097/BPO.0000000000002498.   Erkkila, I. P., Reynolds, C. A., Weissman, J. P., Levine, O. P., Aronson, H., Knoll, J. M., & Larson, J. E. (2023). Factors Associated with Presentation of Severe Adolescent Idiopathic Scoliosis: Original Research. Journal of the Pediatric Orthopaedic Society of North America, 5(3).   Cirrincione PM, Thakur A, Zucker CP, et al. Exploring Correlations Between Pain and Deformity in Idiopathic Scoliosis With Validated Self-reported Pain Scores, Radiographic Measurements, and Trunk Surface Topographic Measurements [published online ahead of print, 2023 Aug 21]. J Pediatr Orthop. 2023;10.1097/BPO.0000000000002493.   Edmonds, E. W., Parvaresh, K. C., Price, M. J., Farnsworth, C. L., Bomar, J. D., Hughes, J. L., & Upasani, V. V. (2023). The Reliability of Measurements for Tibial Torsion: A Comparison of CT, MRI, Biplanar Radiography, and 3D Reconstructions With and Without Standardized Measurement Training: Original Research. Journal of the Pediatric Orthopaedic Society of North America, 5(3).   Miller SD, Juricic M, Bone JN, Steinbok P, Mulpuri K. The Effect of Selective Dorsal Rhizotomy on Hip Displacement in Children With Cerebral Palsy: A Long-term Follow-up Study. J Pediatr Orthop. 2023;43(9):e701-e706.

Understanding Scoliosis Scoliosis is a progressive condition of the spine characterized by a sideways curvature of 10 degrees or greater, including rotation. Progression of scoliosis is almost always guaranteed, but the rate of progression varies significantly. Factors Associated with Scoliosis Progression: Growth – happens at the onset of puberty. It's rapid, unpredictable, not linear but cyclic growth. During this stage, curves can progress very fast. Spinal Degeneration - can lead to the progression of scoliosis, but it tends to be slow initially. Something could happen to cause the spine to start to deteriorate or degenerate. It starts as a small curve but if not corrected will cause further degeneration. Phases of Progression: Puberty: Scoliosis curves tend to progress rapidly during puberty, with some cases even doubling in size in less than six months. Middle Years: The progression rate during this phase is relatively slow and linear, typically around half a degree to one degree per year. Late Stage Life: Scoliosis progression tends to increase as patients age, with curves potentially progressing 7-10 degrees per year. Treatment Options: Traditional Treatment: Limited options exist, especially for adult cases, with a focus on observation or waiting for curves to worsen before considering intervention. The most common recommendation would be to use the Boston Brace, a squeezing style brace to try to stop the spine from worsening in this stage. Conservative Methods: These alternative approaches offer more options for managing scoliosis and aim to reduce the curvature and slow down or reverse progression. Scoliosis-Specific Chiropractic Care: Specialized chiropractic techniques focus on reducing the curve to lessen the likelihood of progression. Scoliosis-Specific Exercises (SSEs): Customized exercises designed for each patient's curve type, age, and abilities to manage and reduce scoliosis progression. Scoliosis-Specific Therapy (SST): Corrective therapy aimed at reducing the curve and improving flexibility. Corrective Bracing: Different from traditional bracing, corrective bracing aims to reduce the curve in combination with the other three approaches mentioned above. Predicting Progression Riser Sign: In children, the growth plate on the hips, known as the Riser Sign, indicates the potential for growth and progression. Size of Curve: Larger curves have a higher likelihood of progression compared to smaller curves. Having known all these, Scoliosis is a progressive condition of the spine that requires proactive management. Watching and waiting do not benefit scoliosis patients, as curves tend to worsen over time. Regular evaluation, proactive treatment, and reducing the curve size quickly are recommended to prevent further progression. For more information on how you can treat scoliosis, check out Dr. Tony Nalda's podcast. Musicbed SyncID: MB016DGYMKU9EIF

Listen to Dr. Graham's interview with Dr. David Ring regarding his paper “Factors Associated with Comfort using Telemedicine for Upper Limb Specialty Care”, which is the lead article in the July 2023 issue of The Journal of Hand Surgery.

In the podcast Swine Extension Educator Sarah Schieck Boelke speaks with Mariana Kikuti, University of Minnesota researcher in the Department of Veterinary Medicine about her research on sow mortality in midwestern USA pig production: reasons for removal and factors associated with increased mortality. Learn more about research featured in the podcast Published in Vet Record, Volume 192, Issue 7, article e2539, DOI: 10.1002/vetr.2539 Summarized on the Swine in Minnesota blog, February 1, 2023

Dr. Iyad Alnahhas interviews Drs. Sherise Ferguson and Michael Davies about their recent manuscript entitled: "Changes in Outcomes and Factors Associated with Survival in Melanoma Patients with Brain Metastases", published online in Neuro-Oncology in December 2022.   Read Paper

Interview with Isdin Oke, MD, author of Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry. Hosted by Neil Bressler, MD. Related Content: Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry

Interview with Isdin Oke, MD, author of Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry. Hosted by Neil Bressler, MD. Related Content: Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry

Full article: https://www.ajronline.org/doi/10.2214/AJR.22.28385 Locoregional therapies for hepatocellular carcinoma perform differently when compared by rates of complete pathologic necrosis of lesions. Juliet Alla, MD discusses a new AJR study that demonstrates improved rates of complete pathologic necrosis for patients with HCC who underwent thermal ablation and TARE therapies, when compared to those who received TACE. Special guest Dr. Zachary Berman, an interventional radiologist who specializes in locoregional therapies for hepatocellular carcinoma, joins to discuss the implications for clinical practice.

Interview with Eric D. Lamarre, MD, author of Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram. Hosted by Paul C. Bryson, MD, MBA. Related Content: Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer

Interview with Eric D. Lamarre, MD, author of Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram. Hosted by Paul C. Bryson, MD, MBA. Related Content: Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer

Welcome to The Brain Podcast - the official podcast for the journal Brain and sister journal Brain Communications. In this episode we are joined by Professor Soon-Tae Lee to discuss his review article entitled Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes. Read the full article on the Brain website: https://doi.org/10.1093/brain/awac166 Maarten Titulaer and Robin van Steenhoven wrote an excellent commentary on the article https://doi.org/10.1093/brain/awac338 We were lucky to have Maarten join us in this podcast discussion. This episode was hosted, edited and produced by Xin You Tai; co-hosted by Sarosh Irani; co-produced by Joanne Bell; original music by Ammar Al-Chalabi.

Comorbidities in Axial Spondyloarthritis Dr. Antoni Chan discusses Abstract 1609 at ACR22 Convergence. Diffuse alveolar hemorrhage in antiphospholipid syndrome Dr. Eric Dein discusses Abstract 0675 at ACR22 Convergence. Abstract 0675: Clinical Characteristics and Factors Associated with Relapse and Mortality in Diffuse Alveolar Hemorrhage Among Patients with Antiphospholipid Syndrome: A Multi-Center Retrospective Cohort Eosinophilia in systemic JIA patients after exposure to biologics Dr. Bella Mehta discusses Abstract 0872 at ACR22 Convergence. Abstract 0872: Incidence, Risk Factors, and Outcomes of Eosinophilia on IL-1 and IL-6 Inhibitors in Systemic and Non-Systemic Juvenile Idiopathic Arthritis Gender differences in Axial Spondyloarthritis Dr. Antoni Chan covered abstracts 0497 and 1614 at ACR22 Convergence in Philadelphia, PA. Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE Dr. Sheila Reyes discusses abstract 1654 at ACR22 Convergence.  Abstract 1654: Hydroxychloroquine Dosing Less Than 5 Mg/kg/day Leads to Increased Hospitalizations for Systemic Lupus Erythematosus Flares Oligoarticular PsA: FOREMOST Study Dr. Peter Nash discusses abstract 1018 at ACR22 Convergence.  Abstract 1018: Characterization of Joint Distribution and Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis: Results from the Ongoing FOREMOST Study Sensor-engineered glove evaluates hand function in RA Dr. David Liew discusses abstract 0904 at ACR22 Convergence.  Abstract 0904: Testing the Hand Function with a Sensor-engineered Glove in Patients with Rheumatoid Arthritis

Can we alter neonatal gut microbiome to prevent spondyloarthritis? Dr Chao discusses Abstract 0868 at the ACR22 Convergence meeting.  Abstract 0868: Spondyloarthritis and Neonatal Factors Affecting the Gut Microbiome JAK vs TNF inhibitor Infections in RA Dr. David Liew discusses abstract 0302 at ACR22 Convergence. Abstract 0302: Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis Opioid and Neuropathic Use After Initiating btsDMARDs in RA Dr. Julian Segan discusses Abstract 0925 at the ACR22 Convergence meeting. The Dietary Intervention in PsA (DIPSA) StudyDr. Patricia Harkins talks with Professor Lihi Eder about abstract 1007 at the ACR22 Convergence meeting.  Abstract 1007: Metabolic Disorders and Abnormal Dietary Patterns and Their Association with Psoriatic Arthritis Activity: The Dietary Intervention in PsA (DIPSA) Study Treatment Considerations in Axial Spondyloarthritis Dr. Lianne Gensler discusses treatment considerations in Axial SpA. Abstract 0402: Opioid Use and Healthcare Utilization in Adults with PsA and AS Abstract 0388: Incidence Rate and Factors Associated with Fractures Among Older Adults with Ankylosing Spondylitis in the United States Abstract 0544: Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study Abstract 0545: Continuing (Full or Reduced Treatment) versus Withdrawing from Golimumab Treatment in Patients with Non-radiographic Spondylarthritis Who Achieved Inactive Disease: Efficacy and Safety Results from a Placebo-Controlled, Randomized Withdrawal and Retreatment Study (GO-BACK) What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Dr Chao discusses Abstract 1510 at ACR22 Convergence. Abstract 1510: Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis – Data from 14 European Countries    

In this replay of episode 92 from 2019, we speak with cardiovascular surgeon Dr. Johann Brink about a recent work he co-authored from the Royal Children's Hospital in Melbourne, Australia about the team's experience with shunt malfunctions. Are there factors that are associated with shunt failure in this sometimes fragile patient group? Survival to Fontan in most series is roughly 70% - what, if anything, can 'move the needle' to higher levels of survival in this patient population? Dr. Brink offers some interesting and important insights this week. doi: 10.1016/j.jtcvs.2019.03.126

Show notes at pharmacyjoe.com/episode702. In this episode, I'll discuss the risk factors associated with the development of venous thromboembolism in ICU patients. The post 702: Risk Factors Associated With the Development of Venous Thromboembolism in Critically Ill Patients appeared first on Pharmacy Joe.

Show notes at pharmacyjoe.com/episode702. In this episode, I ll discuss the risk factors associated with the development of venous thromboembolism in ICU patients. The post 702: Risk Factors Associated With the Development of Venous Thromboembolism in ICU Patients appeared first on Pharmacy Joe.

In the first episode of RAPM Focus, Editor-in-Chief Brian Sites, MD, interviews Stephen P. Cohen, MD, first author of the paper “Multicenter study evaluating factors associated with treatment outcome for low back pain injections”. This prospective study looked at 346 patients receiving one of three procedures: epidural steroid injection for sciatica, sacroiliac joint injections for axial low back pain, and facet interventions for axial low back pain. The study was designed to evaluate associations among more than two dozen demographic, clinical, and technical factors on treatment outcomes. Results found that patients with lower baseline pain scores, depressive symptomatology, and obesity experienced smaller pain reductions. Smoking and sleep deprivation were also associated with poorer outcomes. Dr. Cohen is a professor of anesthesiology and critical care medicine, neurology, physical medicine & rehabilitation and psychiatry and behavioral sciences at the Johns Hopkins School of Medicine and Uniformed Services University of the Health Sciences in Baltimore, MD. He is also chief of pain medicine and director of the Blaustein Pain Treatment Center at Johns Hopkins and director of pain research at Walter Reed National Military Medical Center. @RAPM_Online

Commentary by Dr. Annabelle Voglman

Full journal article can be found at https://fireecology.springeropen.com/articles/10.1186/s42408-021-00117-0

Shefali Christopher from Elon University is our guest for this months Mountain Land Running Medicine Podcast. Dr. Christopher is an assistant professor in the department of physical therapy. She started treating runners 12 years ago because no one else wanted to deal with the triathletes and runners, and slowly built a caseload of predominantly endurance athletes. She has spoken at several local, regional and national conferences about treating the triathlete… The post Biopsychosocial Risk Factors Associated with Pain in Postpartum Runners first appeared on Mountain Land Physical Therapy & Rehabilitation.

On Franklin and Marshall College Week:  Everyone is stressed during the COVID-19 pandemic. Harriet Okatch, assistant professor in the department of biology, examines our stress levels. Harriet Okatch is an Assistant Professor of Public Health at Franklin and Marshall College in Lancaster, PA. With a PhD in Analytical Chemistry and a Masters in Public Health, […]

In this episode, we head over to Norway, to consider a study that examines drug use before and during incarceration and the factors involved in the use of drugs while incarcerated. So much to learn from other country's approaches. Listen and learn. For more information, download the one-pager for this episode (PDF)

Lead author Michelle Barrack and principal investigator Adam S. Tenforde discuss the first investigation into the prevalence of dietary supplement and sport food use in male and female middle school-aged runners. Researchers found that almost half the study participants used these products on two or more days a week during the prior year. Characteristics associated with supplement use included a prior bone stress injury, following a vegetarian diet and behaviors suggesting dietary restrictions such as losing weight and skipping meals. (https://doi.org/10.1016/j.jand.2021.07.013)

Hosts: Ocean Setia is a PGY-4 Vascular Surgery Integrated Resident. Keyuree Satam is a 4th year medical student at Yale.Papers:Cardiac output and cerebral blood flow during carotid surgery in regional versus general anesthesia: A prospective randomized controlled study (https://tinyurl.com/t9fpr3bx)Risk of Stroke before Revascularisation in Patients with Symptomatic Carotid Stenosis: A Pooled Analysis of Randomised Controlled Trials (https://tinyurl.com/4yav9t8x)Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study (https://tinyurl.com/wtfrmss)Simultaneous treatment of common carotid lesions increases the risk of stroke and death after carotid artery stenting (https://tinyurl.com/589sefdn)Outcomes after transfemoral carotid artery stenting stratified by preprocedural symptom status (https://tinyurl.com/4rej8jww)Primary mechanism of stroke reduction in transcarotid artery revascularization is dynamic flow reversal (https://tinyurl.com/4mnxnmnr)Anesthetic choice during transcarotid artery revascularization and carotid endarterectomy affects the risk of myocardial infarction (https://tinyurl.com/z2phxb2x)Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy (https://tinyurl.com/djbn44pw)Carotid Endarterectomy Following Intravenous Thrombolysis in the UK (https://tinyurl.com/2wysy9ay)Quantification and mapping of cerebral hemodynamics before and after carotid endarterectomy, using four-dimensional flow magnetic resonance imaging (https://tinyurl.com/2vzdksxh)CTA-derived area stenosis calculations overestimate degree of carotid stenosis compared with NASCET-derived diameter stenosis calculations (https://tinyurl.com/h756jk8z)Impact of Frailty on Clinical Outcomes after Carotid Artery Revascularization (https://tinyurl.com/2k8v73av)Frailty as a predictor of outcomes for patients undergoing carotid artery stenting (https://tinyurl.com/9ztxemce)Evaluation of Factors Associated with, and Outcomes for Patients with Nonhome Discharge Destinations Following Carotid Endarterectomy (https://tinyurl.com/7p9by58k)Follow Us: Twitter @YaleVascular, Instagram @yalevascularEmail: ocean.setia@yale.edu, keyuree.satam@yale.edu

Liz Curran was inspired to become a health coach after caring for her sister with an aggressive breast cancer diagnosis. She watched her sister struggle during treatment with feeling powerless to aid her own healing. She believed there had to be a roadmap out there to guide people to play a stronger role in their own health.  Liz believes Radical Remission is that map. She uses the 10 healing factors in her own life and guides others to do the same.​In this episode, we discuss:-The power of caring for yourself-Define the 10 healing factors-How to implement the 10 healing factorsContact information for Liz Curran:thehealthnavigators@gmail.comFacebook: https://www.facebook.com/healthnavigatorsInstagram: https://www.instagram.com/healthnavigators/Youtube: https://www.youtube.com/channel/UC35IDQsE8YVcasILMqIU5aA________________________________________________________________________________________1.  Click the link to learn more about the Nurse Wellness Mentorship2. Download your FREE Mindfulness E-Book at stressblueprint.com/353. Follow the Nurse Wellness Podcast on Facebook and Instagram4.Join the Nurse Wellness Hub on Facebook  5. Email Nurse Wellness Podcast at hello@stressblueprint.com6. Background music produced by DNMbeats